A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015K

Clinical trial NCT01486017 · COMPLETED

Trial details

NCT number: NCT01486017
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioavailability of ASP015K Pharmacokinetics of ASP015K Healthy Subjects

Start date: 2011-09-01
Primary completion: 2011-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.